I hope you'll feel better soon, but in general, I don't think we should ignore "good enough" efforts in a futile search for perfection
You can still acknowledge problems while celebrating a win, and push for other improvements while stopping or damping a "hard" boycott (CDNPs are intended for this)
You can still acknowledge problems while celebrating a win, and push for other improvements while stopping or damping a "hard" boycott (CDNPs are intended for this)
November 4, 2026 at 1:34 PM
I hope you'll feel better soon, but in general, I don't think we should ignore "good enough" efforts in a futile search for perfection
You can still acknowledge problems while celebrating a win, and push for other improvements while stopping or damping a "hard" boycott (CDNPs are intended for this)
You can still acknowledge problems while celebrating a win, and push for other improvements while stopping or damping a "hard" boycott (CDNPs are intended for this)
Yeah, CDNPs and participating in the topics to get rid of the problematic tags are both great ways to help sway
Changes are good! They evaporated the slurs they used to have already, for example, so it's not like there is no precedent of them getting rid of controversial tags
Changes are good! They evaporated the slurs they used to have already, for example, so it's not like there is no precedent of them getting rid of controversial tags
November 4, 2026 at 2:04 PM
Yeah, CDNPs and participating in the topics to get rid of the problematic tags are both great ways to help sway
Changes are good! They evaporated the slurs they used to have already, for example, so it's not like there is no precedent of them getting rid of controversial tags
Changes are good! They evaporated the slurs they used to have already, for example, so it's not like there is no precedent of them getting rid of controversial tags
BlueWhale Bio Initiates Groundbreaking Clinical Trial for Cancer Treatment Using Innovative Nanoparticles#USA#Philadelphia#BlueWhale_Bio#Synecta_T1#CDNPs
BlueWhale Bio Initiates Groundbreaking Clinical Trial for Cancer Treatment Using Innovative Nanoparticles
BlueWhale Bio has announced the successful dosing of the first patient in a clinical trial utilizing Synecta™ T1 cell-derived nanoparticles, focusing on enhanced immune therapies for cancer treatment.
third-news.com
September 3, 2025 at 12:30 PM
BlueWhale Bio Initiates Groundbreaking Clinical Trial for Cancer Treatment Using Innovative Nanoparticles#USA#Philadelphia#BlueWhale_Bio#Synecta_T1#CDNPs
